Literature DB >> 11090993

Protective effect of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) against impairment of learning and memory induced by transient cerebral ischemia in mice.

J Xu1, Y Murakami, K Matsumoto, M Tohda, H Watanabe, S Zhang, Q Yu, J Shen.   

Abstract

The protective effect of Oren-gedoku-to (OGT; Huang-Lian-Jie-Du-Tang), a traditional Chinese medicine, against impairment of learning and memory induced by transient cerebral ischemia was investigated in mice. The cerebral ischemia caused a reduction of step-down latency and an increase of step-down errors in the passive avoidance task. Pretreatment with oral administration of OGT (2, 4 or 8 g of herbs per kg) once daily for 5 days prolonged the step-down latency significantly and decreased the step-down errors as compared with those of sham-operated controls. In the Morris water maze test, the cerebral ischemia caused an increase in the latency until finding the platform in the training trial and a decrease in the percentage of swimming in the quadrant of the former platform in the probe trial. Oren-gedoku-to (OGT; 2, 4 and 8 g/kg, p. o.) shortened the latency of escaping markedly onto the platform in the training trial and increased the percentage of crossing the former platform quadrant in the probe trial. A reference drug, tacrine (0.5 and 1.0 mg/kg, p.o.), prevented the reduction of step-down latency in the passive avoidance task and shortened the escape latency in the Morris water maze task. Furthermore, OGT significantly protected against cerebral ischemia-induced reduction in the acetylcholine (ACh) content of the cerebral cortex, hippocampus and striatum. These results indicate that the protective effects of OGT against the impairment of learning and memory induced by transient cerebral ischemia may be associated with preventing the decrease in the ACh content of the mouse brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090993     DOI: 10.1016/s0378-8741(00)00303-2

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  17 in total

1.  Protection of long-term treatment with huang-lian-jie-du-tang on vascular endothelium in rats with type 2 diabetes mellitus.

Authors:  Quan Yi; Xiao-En He; Kai-Fey Luo; Gen-Shui Zhang; Ying-Hua Liu; Qin Xue; Ning Hou; Wen-Liang Chen; Jian-Dong Luo
Journal:  Curr Ther Res Clin Exp       Date:  2012-12

2.  The Neuroprotective and Neurotrophic Effects of Tremella fuciformis in PC12h Cells.

Authors:  Kum Ju Park; Sang-Yun Lee; Hyun-Su Kim; Matsumi Yamazaki; Kenzo Chiba; Hyo-Cheol Ha
Journal:  Mycobiology       Date:  2007-03-31       Impact factor: 1.858

3.  Effects of Huanglian-Jie-Du-Tang and its modified formula on the modulation of amyloid-β precursor protein processing in Alzheimer's disease models.

Authors:  Siva Sundara Kumar Durairajan; Ying-Yu Huang; Pui-Yee Yuen; Lei-Lei Chen; Ka-Yan Kwok; Liang-Feng Liu; Ju-Xian Song; Quan-Bin Han; Lei Xue; Sookja K Chung; Jian-Dong Huang; Larry Baum; Sanjib Senapati; Min Li
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

4.  Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang.

Authors:  Chang-Seob Seo; Ohn Soon Kim; Jung-Hoon Kim; Hyeun-Kyoo Shin
Journal:  BMC Complement Altern Med       Date:  2015-04-08       Impact factor: 3.659

5.  Inhibition activity of a traditional Chinese herbal formula Huang-Lian-Jie-Du-Tang and its major components found in its plasma profile on neuraminidase-1.

Authors:  Xuelin Zhou; Haotian Li; Zhilong Shi; Sijia Gao; Shizhang Wei; Kun Li; Jiabo Wang; Jianyu Li; Ruilin Wang; Man Gong; Yanling Zhao; Xiaohe Xiao
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

6.  The components of Huang-Lian-Jie-Du-Decoction act synergistically to exert protective effects in a rat ischemic stroke model.

Authors:  Qian Zhang; Junsong Wang; Chao Zhang; Shanting Liao; Pei Li; Dingqiao Xu; Yan Lv; Minghua Yang; Lingyi Kong
Journal:  Oncotarget       Date:  2016-12-06

7.  Baicalin's Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative Effects In Vitro and In Vivo.

Authors:  Fafeng Cheng; Yi Lu; Xianggen Zhong; Wenting Song; Xueqian Wang; Xiaoguang Sun; Jianguo Qin; Shaoying Guo; Qingguo Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

8.  Bioinformatics analysis for the antirheumatic effects of huang-lian-jie-du-tang from a network perspective.

Authors:  Haiyang Fang; Yichuan Wang; Tinghong Yang; Yang Ga; Yi Zhang; Runhui Liu; Weidong Zhang; Jing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-21       Impact factor: 2.629

9.  Treatment Effects of Ischemic Stroke by Berberine, Baicalin, and Jasminoidin from Huang-Lian-Jie-Du-Decoction (HLJDD) Explored by an Integrated Metabolomics Approach.

Authors:  Qian Zhang; Xiaowei Fu; Junsong Wang; Minghua Yang; Lingyi Kong
Journal:  Oxid Med Cell Longev       Date:  2017-08-14       Impact factor: 6.543

10.  Preparation, Characterization, Pharmacokinetics and Biodistribution of Baicalin-Loaded Liposome on Cerebral Ischemia-Reperfusion after i.v. Administration in Rats.

Authors:  Nan Li; Lingling Feng; Yujun Tan; Yan Xiang; Ruoqi Zhang; Ming Yang
Journal:  Molecules       Date:  2018-07-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.